Together, this suggests that an involvement of PEA-15 in PCOS as well as in the insulin resistance, commonly associated with the disease, and by targeting PEA-15 or a component of the signalling pathway by pharmacological intervention could potentially alleviate some of the symptoms of PCOS. Here, PEA15 is linked to polycystic ovary syndrome.